Development of preclinical diagnosis and preventive treatment of neurodegenerative diseases
Author:
- 1 January 2015
- journal article
- abstracts
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 115 (11) , 4-14
Abstract
Neurodegenerative diseases (NDD) are serious fatal neurological and mental diseases that resulted in disability and fethal outcome. Based on the advances of basic sciences over the last two decades, new knowledge on the risk factors for NDD and molecular mechanisms of the pathogenesis are obtained. It has been shown that the accelerated process of neuronal death which is the main cause of NDD development begins long before the appearance of clinical symptoms. The first symptoms appeared only after the death of most specific regulatory neurons and exhaustion of brain compensatory reserve. Only at that time, one can make the diagnosis and start traditional treatment of patients that accounts for the extremely low efficacy of the latter. Currently, complex preclinical diagnosis based on the identification of relatively specific clinical precursors and peripheral biomarkers has been developing. Development of preclinical diagnosis and preventive treatment is a strategic issue of modern neurology and psychiatry. The resolution of this issue allows to consider NDD as cured, but not fatal, diseases.Keywords
This publication has 101 references indexed in Scilit:
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the LiteratureJournal of Neuropathology & Experimental Neurology, 2012
- Premotor Parkinson's disease: Concepts and definitionsMovement Disorders, 2012
- Functional Neuroimaging in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the diseaseBritish Journal of Pharmacology, 2011
- Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of LevodopaNeuropsychopharmacology, 2011
- Parkinson’s disease mouse models in translational researchMammalian Genome, 2011
- Review Article: Genetics of Alzheimer DiseaseJournal of Geriatric Psychiatry and Neurology, 2010
- Targets for neuroprotection in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Genetic Aspects of Alzheimer DiseaseThe Neurologist, 2009
- Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophyParkinsonism & Related Disorders, 2008